EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access · CC BY 4.0

Molecular Proliferation Marker Ki-67 in Breast Cancer: The Role of Vitamin D Status, Hormone Receptor Expression, and Clinicopathological Factors—A Cross-Sectional Study

Dorota Weber, Robert Łuczyk iD, Anna Pacian, Teresa Kulik, Monika Baryła-Matejczuk iD

International Journal of Molecular Sciences · 01.10.2026 · 27 (19) · 8797

DOI: 10.3390/ijms27198797 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 01.10.2026. Verfasst von Dorota Weber und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Health Sciences, WSEI University, 20-209 Lublin, Poland. Hauptthemen laut MEDLINE: Ki-67 Antigen, Breast Neoplasms, Receptors, Estrogen, Receptors, Progesterone. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ki-67 is a well-established nuclear biomarker of tumor cell proliferation with key importance for the molecular classification and prognostic stratification of breast cancer. This cross-sectional study included 101 women with histopathologically confirmed invasive breast cancer treated at the St. John of Dukla Oncology Center of the Lublin Region (COZL), Poland (2018–2019). Ki-67 expression was assessed immunohistochemically on formalin-fixed, paraffin-embedded tumor tissue, and independent predictors were identified using multiple linear regression. The median Ki-67 was 20% (IQR: 15–40%). Ki-67 differed significantly between molecular subtypes (Kruskal–Wallis test H = 16.122; p = 0.001; η2 = 0.138): Luminal A tumors had the lowest Ki-67 (median 18%), whereas the Luminal B, HER2-enriched, and Triple-negative subtypes showed higher values (median 30% each). Ki-67 was significantly lower in tumors expressing the estrogen receptor (p = 0.005) and progesterone receptor (p = 0.023). Because the Luminal A/B distinction incorporates a Ki-67 threshold by definition, a multivariable model excluding molecular subtype was fitted using ER, PR, HER2, menopausal status, age, BMI category, and 25(OH)D as candidate predictors. This model identified HER2 positivity (b = 11.26; p = 0.024) and postmenopausal status (b = 17.93; p = 0.017) as independent predictors of higher Ki-67, with a borderline inverse association for age (b = −0.65; p = 0.092); the model explained 10.1% of variance (R2 = 0.101; F(3,95) = 3.574; p = 0.017), and neither ER, PR, BMI, nor 25(OH)D were retained. Serum 25(OH)D concentration showed no meaningful association with Ki-67, either unadjusted (Spearman ρ = 0.035; p = 0.730) or when forced into the retained multivariable model regardless of significance (adjusted b = −0.032; 95% CI: −0.337–0.272; p = 0.834); no association was observed between circulating 25(OH)D and Ki-67 in this cohort, although indirect biological relationships cannot be excluded.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ki-67 AntigenBreast NeoplasmsReceptors, EstrogenReceptors, ProgesteroneBiomarkers, TumorVitamin DHumansFemaleCross-Sectional StudiesErb-b2 Receptor Tyrosine KinasesMiddle AgedAgedAdultCell ProliferationPrognosis

Stichwörter der Autor:innen

25-hydroxyvitamin DBMIHER2Ki-67breast cancerestrogen receptorimmunohistochemistrymenopausal statusmolecular subtypesprogesterone receptor

Substanzen

Ki-67 AntigenReceptors, EstrogenReceptors, ProgesteroneErb-b2 Receptor Tyrosine KinasesBiomarkers, TumorVitamin DERBB2 protein, human

Autor:innen und Institutionen

  • Faculty of Health Sciences, WSEI University, 20-209 Lublin, Poland.
  • Faculty of Medical and Health Sciences, University of Siedlce, 08-110 Siedlce, Poland.
  • Department of Health Education, Faculty of Nursing Development, Medical University in Lublin, 20-059 Lublin, Poland.
  • Institute of Psychology and Pedagogy, WSEI University, 20-209 Lublin, Poland.

ORCID-Profile: Robert Łuczyk, Monika Baryła-Matejczuk

Zitieren

APA

Weber, D., Łuczyk, R., Pacian, A., Kulik, T., & Baryła-Matejczuk, M. (2026). Molecular Proliferation Marker Ki-67 in Breast Cancer: The Role of Vitamin D Status, Hormone Receptor Expression, and Clinicopathological Factors—A Cross-Sectional Study. International Journal of Molecular Sciences, 27(19), 8797. https://doi.org/10.3390/ijms27198797

Vancouver

Weber D, Łuczyk R, Pacian A, Kulik T, Baryła-Matejczuk M. Molecular Proliferation Marker Ki-67 in Breast Cancer: The Role of Vitamin D Status, Hormone Receptor Expression, and Clinicopathological Factors—A Cross-Sectional Study. International Journal of Molecular Sciences. 2026;27(19):8797. doi:10.3390/ijms27198797

BibTeX
@article{Weber2026,
  author = {Weber, Dorota and Łuczyk, Robert and Pacian, Anna and Kulik, Teresa and Baryła-Matejczuk, Monika},
  title = {Molecular Proliferation Marker Ki-67 in Breast Cancer: The Role of Vitamin D Status, Hormone Receptor Expression, and Clinicopathological Factors—A Cross-Sectional Study},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {19},
  pages = {8797},
  doi = {10.3390/ijms27198797}
}
Kostenlos starten →